BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 33827115)

  • 21. Opposing effects of CD70 costimulation during acute and chronic lymphocytic choriomeningitis virus infection of mice.
    Penaloza-MacMaster P; Ur Rasheed A; Iyer SS; Yagita H; Blazar BR; Ahmed R
    J Virol; 2011 Jul; 85(13):6168-74. PubMed ID: 21507976
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunodeficiency and EBV-induced lymphoproliferation caused by 4-1BB deficiency.
    Alosaimi MF; Hoenig M; Jaber F; Platt CD; Jones J; Wallace J; Debatin KM; Schulz A; Jacobsen E; Möller P; Shamseldin HE; Abdulwahab F; Ibrahim N; Alardati H; Almuhizi F; Abosoudah IF; Basha TA; Chou J; Alkuraya FS; Geha RS
    J Allergy Clin Immunol; 2019 Aug; 144(2):574-583.e5. PubMed ID: 30872117
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of the CD4+ T cell response to Epstein-Barr virus during primary and persistent infection.
    Amyes E; Hatton C; Montamat-Sicotte D; Gudgeon N; Rickinson AB; McMichael AJ; Callan MF
    J Exp Med; 2003 Sep; 198(6):903-11. PubMed ID: 12975456
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Specificity of T cells in synovial fluid: high frequencies of CD8(+) T cells that are specific for certain viral epitopes.
    Tan LC; Mowat AG; Fazou C; Rostron T; Roskell H; Dunbar PR; Tournay C; Romagné F; Peyrat MA; Houssaint E; Bonneville M; Rickinson AB; McMichael AJ; Callan MF
    Arthritis Res; 2000; 2(2):154-64. PubMed ID: 11062606
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MicroRNAs of Epstein-Barr Virus Attenuate T-Cell-Mediated Immune Control
    Murer A; Rühl J; Zbinden A; Capaul R; Hammerschmidt W; Chijioke O; Münz C
    mBio; 2019 Jan; 10(1):. PubMed ID: 30647153
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Functional Epstein-Barr virus reservoir in plasma cells derived from infected peripheral blood memory B cells.
    Al Tabaa Y; Tuaillon E; Bollore K; Foulongne V; Petitjean G; Seigneurin JM; Duperray C; Desgranges C; Vendrell JP
    Blood; 2009 Jan; 113(3):604-11. PubMed ID: 18845794
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activating PIK3CD mutations impair human cytotoxic lymphocyte differentiation and function and EBV immunity.
    Edwards ESJ; Bier J; Cole TS; Wong M; Hsu P; Berglund LJ; Boztug K; Lau A; Gostick E; Price DA; O'Sullivan M; Meyts I; Choo S; Gray P; Holland SM; Deenick EK; Uzel G; Tangye SG
    J Allergy Clin Immunol; 2019 Jan; 143(1):276-291.e6. PubMed ID: 29800648
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epstein-Barr virus evasion of CD8(+) and CD4(+) T cell immunity via concerted actions of multiple gene products.
    Ressing ME; Horst D; Griffin BD; Tellam J; Zuo J; Khanna R; Rowe M; Wiertz EJ
    Semin Cancer Biol; 2008 Dec; 18(6):397-408. PubMed ID: 18977445
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of the 2B4 Receptor in CD8+ T-Cell-Dependent Immune Control of Epstein-Barr Virus Infection in Mice With Reconstituted Human Immune System Components.
    Chijioke O; Marcenaro E; Moretta A; Capaul R; Münz C
    J Infect Dis; 2015 Sep; 212(5):803-7. PubMed ID: 25722295
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detailed analysis of Epstein-Barr virus-specific CD4+ and CD8+ T cell responses during infectious mononucleosis.
    Scherrenburg J; Piriou ER; Nanlohy NM; van Baarle D
    Clin Exp Immunol; 2008 Aug; 153(2):231-9. PubMed ID: 18549439
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CD27 costimulation contributes substantially to the expansion of functional memory CD8(+) T cells after peptide immunization.
    Taraban VY; Rowley TF; Kerr JP; Willoughby JE; Johnson PM; Al-Shamkhani A; Buchan SL
    Eur J Immunol; 2013 Dec; 43(12):3314-23. PubMed ID: 24002868
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Retrovirus-mediated gene transfer in polyclonal T cells results in lower apoptosis and enhanced ex vivo cell expansion of CMV-reactive CD8 T cells as compared with EBV-reactive CD8 T cells.
    Sauce D; Rufer N; Mercier P; Bodinier M; Rémy-Martin JP; Duperrier A; Ferrand C; Hervé P; Romero P; Lang F; Tiberghien P; Robinet E
    Blood; 2003 Aug; 102(4):1241-8. PubMed ID: 12730101
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modulation of interleukin-7 receptor expression characterizes differentiation of CD8 T cells specific for HIV, EBV and CMV.
    Boutboul F; Puthier D; Appay V; Pellé O; Ait-Mohand H; Combadière B; Carcelain G; Katlama C; Rowland-Jones SL; Debré P; Nguyen C; Autran B
    AIDS; 2005 Nov; 19(17):1981-6. PubMed ID: 16260904
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epstein-Barr Virus-Specific CD8 T Cells Selectively Infiltrate the Brain in Multiple Sclerosis and Interact Locally with Virus-Infected Cells: Clue for a Virus-Driven Immunopathological Mechanism.
    Serafini B; Rosicarelli B; Veroni C; Mazzola GA; Aloisi F
    J Virol; 2019 Dec; 93(24):. PubMed ID: 31578295
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clonotype selection and composition of human CD8 T cells specific for persistent herpes viruses varies with differentiation but is stable over time.
    Iancu EM; Corthesy P; Baumgaertner P; Devevre E; Voelter V; Romero P; Speiser DE; Rufer N
    J Immunol; 2009 Jul; 183(1):319-31. PubMed ID: 19542443
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acute Virus Control Mediated by Licensed NK Cells Sets Primary CD8+ T Cell Dependence on CD27 Costimulation.
    Teoh JJ; Gamache AE; Gillespie AL; Stadnisky MD; Yagita H; Bullock TN; Brown MG
    J Immunol; 2016 Dec; 197(11):4360-4370. PubMed ID: 27798162
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Costimulatory ligand CD70 allows induction of CD8+ T-cell immunity by immature dendritic cells in a vaccination setting.
    Keller AM; Xiao Y; Peperzak V; Naik SH; Borst J
    Blood; 2009 May; 113(21):5167-75. PubMed ID: 19279334
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulation of human cell engraftment and development of EBV-related lymphoproliferative disorders in Hu-PBL-scid mice.
    Wagar EJ; Cromwell MA; Shultz LD; Woda BA; Sullivan JL; Hesselton RM; Greiner DL
    J Immunol; 2000 Jul; 165(1):518-27. PubMed ID: 10861091
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cooperation between Epstein-Barr virus immune evasion proteins spreads protection from CD8+ T cell recognition across all three phases of the lytic cycle.
    Quinn LL; Zuo J; Abbott RJ; Shannon-Lowe C; Tierney RJ; Hislop AD; Rowe M
    PLoS Pathog; 2014 Aug; 10(8):e1004322. PubMed ID: 25144360
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytotoxic CD4+ T cell responses to EBV contrast with CD8 responses in breadth of lytic cycle antigen choice and in lytic cycle recognition.
    Long HM; Leese AM; Chagoury OL; Connerty SR; Quarcoopome J; Quinn LL; Shannon-Lowe C; Rickinson AB
    J Immunol; 2011 Jul; 187(1):92-101. PubMed ID: 21622860
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.